Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Courting Hope In Alzheimer’s: Intellect Neurosciences Sues Pfizer For $2 Million Licensing Fee

Oct 15 2012

• By Brenda Sandburg

Related Content

Bapineuzumab Failure Raises More Doubts About Beta Amyloid Approach In Alzheimer’s

Jul 24 2012

Related Companies

Intellect Neurosciences, Inc.

Pfizer Inc.

Wyeth

Elan Corporation

Eli Lilly and Company

Additional Topics

Legal Issues BioPharmaceutical

More from Legal & IP

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window